−2.59CNY
−736.00 MCNY
206.17 M
About DIZAL (JIANGSU) PHARMACEUTICAL
Sector
CEO
Xiao Lin Zhang
Website
Headquarters
Shanghai
Founded
2017
ISIN
CNE1000055W8
FIGI
BBG00ZLKRN31
Dizal (Jiangsu) Pharmaceutical Co., Ltd. engages in the discovery, development, and commercialization of innovative medicines. It researches, develops translational science, new-drug molecular design, and screening technology for the treatment of cancer, immunological diseases, and chronic kidney diseases. The company was founded by Xiao Lin Zhang on October 27, 2017 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 688192 is 37.21 CNY — it has decreased by 6.98% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange DIZAL (JIANGSU) PHARMACEUTICAL stocks are traded under the ticker 688192.
DIZAL (JIANGSU) PHARMACEUTICAL is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for DIZAL (JIANGSU) PHARMACEUTICAL has a max estimate of 54.00 CNY and a min estimate of 54.00 CNY.
Yes, you can track DIZAL (JIANGSU) PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
Like other stocks, 688192 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIZAL (JIANGSU) PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.